Investment and M&A transaction comps
CPG Investment & M&A Transaction Comps
Global CPG and consumer brand investments, capital raises and M&A transactions, including food, beverage, beauty, personal care, supplements and adjacent branded consumer categories.
101
Reviewed transactions
69
With price data
4.5x
Median EV or valuation / revenue
17.0x
Median EV or valuation / EBITDA
| Year | Transactions | Priced | Median EV or valuation / revenue | Median EV or valuation / EBITDA |
|---|---|---|---|---|
| 2026 | 6 | 5 | 2.9x | 9.9x |
| 2024 | 6 | 6 | 4.2x | 16.0x |
| 2023 | 14 | 12 | 4.1x | 21.6x |
| 2022 | 16 | 6 | 4.9x | 20.4x |
| 2021 | 18 | 14 | 4.7x | 15.0x |
| 2020 | 10 | 5 | 4.2x | 14.7x |
| 2019 | 6 | 5 | 4.4x | 18.7x |
| 2018 | 4 | 4 | 4.5x | 21.2x |
Sortable transaction comps
CPG transaction table
Rows with reported value
22 / 25
Acquisition value, USD
USD 15B
Investment capital, USD
USD 282M
Median EV or valuation / revenue
3.8x
Select up to 12 rows across filters and pages, then share or export the set.
Selected comparison set
Saved in this browser only. Nothing is written to FundComb data.
Choose transactions from the table to build a quick comparison set.
25 shown of 101 matching transactions. Click any transaction row for more detail.
| Select for comparison | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Thorne Control | 2026-08-04 | Procter & Gamble | USD 3.8B Consideration | 3,800 | - | - | United States | Estimated 1 source | ||
| The European Candy Group B.V. Control (100%) | 2026-07-31 | Orkla Snacks (Orkla ASA) | EUR 207M Enterprise Value | 235 | 1.9x | 9.9x | Netherlands (Drachten; facilities in Netherlands and Germany) | Confirmed 1 source | ||
| Saltair Control | 2026-07-30 | TSG Consumer | USD 458M Estimated Valuation | 458 | 4.6x | 15.3x | Los Angeles, California, USA | Confirmed 2 sources | ||
| Vitabiotics Control | 2026-07-24 | Bain Capital | Undisclosed Undisclosed | Undisclosed | - | - | United Kingdom | Confirmed 1 source | ||
| Sudsies, Inc. Control (29%) | 2026-07-20 | EVI Industries, Inc. | USD 34.6M Consideration | 35 | 1.6x | 6.1x | Miami, Florida, USA | Estimated 1 source | ||
| Grüns Control (80%) | 2026-04-09 | Unilever | EUR 767M Consideration | 896 | 4.0x | - | United States | Estimated 2 sources | ||
| Huel Control (100%) | 2026-03-23 | Danone | EUR 1.0B Enterprise Value | 1,160 | 3.5x | 34.8x | United Kingdom | Estimated 3 sources | ||
| Beautynova Control | 2024-03-18 | PAI Partners | EUR 330M | 365 | 2.5x | 10.6x | Italy | Estimated 1 source | ||
| ChapStick Control | 2024-01-25 | Suave Brands Company | USD 510M Consideration | 510 | - | - | Global | Estimated 1 source | ||
| Ultra Violette Capital Raise | 2024-01-23 | Aria Growth Partners | AUD 15.0M Investment Amount | 10 | - | - | Australia | Confirmed 1 source | ||
| RoC Skincare Control | 2024-01-23 | Bridgepoint | EUR 462M | 511 | 3.3x | 20.0x | - | Estimated 1 source | ||
| Sunday Natural Control (55%) | 2024-01-15 | CVC Capital Partners | EUR 800M Enterprise Value | 875 | 8.0x | 16.0x | Germany | Estimated 1 source | ||
| Dr. Barbara Sturm Control | 2024-01-01 | Puig | EUR 320M | 354 | 5.0x | - | - | Estimated 2 sources | ||
| Go-To Skincare Control | 2023-12-15 | Zoë Foster Blake | AUD 21.8M Consideration | 15 | - | - | Australia | Confirmed 1 source | ||
| Straand Capital Raise | 2023-12-10 | Unilever Ventures | USD 4.0M Investment Amount | 4 | - | - | Australia | Confirmed 1 source | ||
| Lactobio Control | 2023-12-04 | L’Oréal | Undisclosed Undisclosed | Undisclosed | - | - | Denmark | Confirmed 1 source | ||
| Bonafide Health Control | 2023-11-30 | Pharmavite | USD 425M Consideration | 425 | - | - | - | Confirmed 1 source | ||
| COSRX Control (38%) | 2023-10-30 | Amorepacific | USD 1.0B | 1,000 | 3.6x | - | South Korea | Confirmed 2 sources | ||
| Viatris OTC business Control | 2023-10-01 | Cooper Consumer Health | EUR 1.9B Consideration | 2,066 | - | - | Europe | Confirmed 2 sources | ||
| La Rosée Minority (20%) | 2023-09-09 | FG Bros | EUR 250M Investment Amount | 268 | 4.5x | 14.2x | - | Confirmed 1 source | ||
| Naturium Control | 2023-08-29 | Elf | EUR 328M | 354 | 3.9x | 20.9x | US (California) | Estimated 1 source | ||
| Thorne HealthTech Control | 2023-08-28 | L Catterton | USD 681M Enterprise Value | 681 | 3.7x | 21.2x | - | Estimated 2 sources | ||
| Lamisil Control | 2023-08-01 | Karo Healthcare | Undisclosed | Undisclosed | 4.1x | - | - | Confirmed 1 source | ||
| Bondi Sands Control | 2023-08-01 | Kao Corporation | AUD 450M Consideration | 298 | 4.2x | - | Australia | Confirmed 1 source | ||
| Blackmores Control (100%) | 2023-04-26 | Kirin | USD 1.2B Enterprise Value | 1,241 | 2.9x | 23.1x | Australia | Estimated 3 sources |
FundComb transaction comps are informational only. Prices are shown as estimated enterprise value where available, with USD used as the default sorting currency; revenue and EBITDA multiples are shown where available. Values may be estimated, rumored, incomplete or derived from public information and should not be relied upon as financial, investment or valuation advice.